Assessment of the Effectiveness of a Protocol to Manage Dexamethasone-Induced Hyperglycemia Among Hospitalized Patients With COVID-19

OBJECTIVE: Well-controlled glucose levels (ie, 70-180 mg/dL) have been associated with lower mortality from COVID-19. The addition of dexamethasone to COVID-19 treatment protocols has raised concerns about the potential negative consequences of dexamethasone-induced hyperglycemia. METHODS: We develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Asiri, Alanood A., Alguwaihes, Abdullah M., Jammah, Anwar A., Alfadda, Assim A., Al-Sofiani, Mohammed E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AACE. Published by Elsevier Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330151/
https://www.ncbi.nlm.nih.gov/pubmed/34358694
http://dx.doi.org/10.1016/j.eprac.2021.07.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330151/
https://www.ncbi.nlm.nih.gov/pubmed/34358694
http://dx.doi.org/10.1016/j.eprac.2021.07.016

Ejemplares similares